4//SEC Filing
Bertram Timothy 4
Accession 0001209191-21-012356
CIK 0001538210other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:22 PM ET
Size
14.5 KB
Accession
0001209191-21-012356
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
Bertram Timothy
Director
Transactions
- Conversion
Common Stock
2021-02-17+44,965→ 51,415 total - Conversion
Common Stock
2021-02-17+10,344→ 61,759 total - Conversion
Common Stock
2021-02-17+16,440→ 78,199 total - Conversion
Series A Preferred Stock
2021-02-17−44,965→ 0 total→ Common Stock (44,965 underlying) - Conversion
Series A2 Preferred Stock
2021-02-17−10,344→ 0 total→ Common Stock (10,344 underlying) - Conversion
Series A3 Stock
2021-02-17−16,440→ 0 total→ Common Stock (16,440 underlying)
Footnotes (3)
- [F1]The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis.
- [F2]The shares of preferred stock were convertible into the Issuer's common stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering.
- [F3]Not applicable.
Documents
Issuer
NexImmune, Inc.
CIK 0001538210
Entity typeother
Related Parties
1- filerCIK 0001488033
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:22 PM ET
- Size
- 14.5 KB